MEDS (TRxADE HEALTH) רווח נקי למניה (EPS TTM)

Despite liquidity shortages and the use of credit lines to support operations, TRxADE HEALTH, Inc. (MEDS) is developing a B2B marketplace that generates a steady stream of commissions from pharmacies. The company's TTM net income per share on GURU.Markets reflects this trend, where the value -43.04 captures the metric level. Simultaneously, the business is optimizing pharmaceutical supply chains, reducing transportation costs through a digital environment.

Investors are seeking objective capital efficiency criteria within the financial reporting of TRxADE HEALTH, Inc. (MEDS). The EPS TTM metric measures the net profit per common share over a year, excluding the impact of one-time factors. By analyzing the EPS trend over the last 12 months, one can assess the dynamics of the business's real profitability. Growth in this metric confirms the success of digitizing pharmacy logistics and reducing costs through ESG optimization. A steady increase in profit proves the scalability of the company's eco-friendly IT solutions.